Search details
1.
Phenotypic determinism and stochasticity in antibody repertoires of clonally expanded plasma cells.
Proc Natl Acad Sci U S A
; 119(18): e2113766119, 2022 05 03.
Article
in English
| MEDLINE | ID: mdl-35486691
2.
Distinctive binding properties of human monoclonal LGI1 autoantibodies determine pathogenic mechanisms.
Brain
; 143(6): 1731-1745, 2020 06 01.
Article
in English
| MEDLINE | ID: mdl-32437528
3.
Efficacy of an Inhaled IL-13 Antibody Fragment in a Model of Chronic Asthma.
Am J Respir Crit Care Med
; 198(5): 610-619, 2018 09 01.
Article
in English
| MEDLINE | ID: mdl-29883204
4.
Epitope determines efficacy of therapeutic anti-Tau antibodies in a functional assay with human Alzheimer Tau.
Acta Neuropathol
; 136(5): 729-745, 2018 11.
Article
in English
| MEDLINE | ID: mdl-30238240
5.
Symmetric dimethylation of poly-GR correlates with disease duration in C9orf72 FTLD and ALS and reduces poly-GR phase separation and toxicity.
Acta Neuropathol
; 139(2): 407-410, 2020 02.
Article
in English
| MEDLINE | ID: mdl-31832771
6.
Generation of a single-cell B cell atlas of antibody repertoires and transcriptomes to identify signatures associated with antigen specificity.
iScience
; 26(3): 106055, 2023 Mar 17.
Article
in English
| MEDLINE | ID: mdl-36852274
7.
CD1a promotes systemic manifestations of skin inflammation.
Nat Commun
; 13(1): 7535, 2022 12 07.
Article
in English
| MEDLINE | ID: mdl-36477177
8.
A conformation-selective monoclonal antibody against a small molecule-stabilised signalling-deficient form of TNF.
Nat Commun
; 12(1): 583, 2021 01 25.
Article
in English
| MEDLINE | ID: mdl-33495445
9.
Rapid isolation of antigen-specific B-cells using droplet microfluidics.
RSC Adv
; 10(45): 27006-27013, 2020 Jul 15.
Article
in English
| MEDLINE | ID: mdl-35515810
10.
Cyto-Mine: An Integrated, Picodroplet System for High-Throughput Single-Cell Analysis, Sorting, Dispensing, and Monoclonality Assurance.
SLAS Technol
; 25(2): 177-189, 2020 04.
Article
in English
| MEDLINE | ID: mdl-31941402
11.
Generation of two high affinity anti-mouse FcRn antibodies: Inhibition of IgG recycling in wild type mice and effect in a mouse model of immune thrombocytopenia.
Int Immunopharmacol
; 66: 362-365, 2019 Jan.
Article
in English
| MEDLINE | ID: mdl-30529500
12.
Recognition of Amino Acid Motifs, Rather Than Specific Proteins, by Human Plasma Cell-Derived Monoclonal Antibodies to Posttranslationally Modified Proteins in Rheumatoid Arthritis.
Arthritis Rheumatol
; 71(2): 196-209, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30152202
13.
Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated Humans.
Cell Rep
; 27(1): 172-186.e7, 2019 04 02.
Article
in English
| MEDLINE | ID: mdl-30943399
14.
Generation and characterization of a high affinity anti-human FcRn antibody, rozanolixizumab, and the effects of different molecular formats on the reduction of plasma IgG concentration.
MAbs
; 10(7): 1111-1130, 2018 10.
Article
in English
| MEDLINE | ID: mdl-30130439
15.
Blockade of colony stimulating factor-1 (CSF-I) leads to inhibition of DSS-induced colitis.
Inflamm Bowel Dis
; 13(2): 219-24, 2007 Feb.
Article
in English
| MEDLINE | ID: mdl-17206685
16.
Antibody generation through B cell panning on antigen followed by in situ culture and direct RT-PCR on cells harvested en masse from antigen-positive wells.
J Immunol Methods
; 316(1-2): 133-43, 2006 Oct 20.
Article
in English
| MEDLINE | ID: mdl-17027850
17.
Generation of Recombinant Monoclonal Antibodies from Immunised Mice and Rabbits via Flow Cytometry and Sorting of Antigen-Specific IgG+ Memory B Cells.
PLoS One
; 11(3): e0152282, 2016.
Article
in English
| MEDLINE | ID: mdl-27022949
18.
Modulation of CSF-1-regulated post-natal development with anti-CSF-1 antibody.
Immunobiology
; 210(2-4): 109-19, 2005.
Article
in English
| MEDLINE | ID: mdl-16164017
19.
A fully automated primary screening system for the discovery of therapeutic antibodies directly from B cells.
J Biomol Screen
; 20(4): 492-7, 2015 Apr.
Article
in English
| MEDLINE | ID: mdl-25548140
20.
Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes.
Sci Transl Med
; 7(319): 319ra205, 2015 Dec 23.
Article
in English
| MEDLINE | ID: mdl-26702093